Caribou Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Caribou Biosciences using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-12 | $-0.30 | $-0.36 | 16.7 % |
| Q2 | 2025-08-12 | $-0.35 | $-0.41 | 14.6 % |
| Q1 | 2025-05-08 | $-0.43 | $-0.48 | 10.4 % |
| Q4 | 2025-03-10 | $-0.39 | $-0.42 | 7.14 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-12 | $2.20M | $2.14M | 2.60 % |
| Q2 | 2025-08-12 | $2.67M | $1.98M | 34.6 % |
| Q1 | 2025-05-08 | $2.35M | $1.44M | 63.4 % |
| Q4 | 2025-03-10 | $2.08M | $1.84M | 12.9 % |
Caribou Biosciences (CRBU) is scheduled to report earnings on March 9, 2026. The last reported earnings were for reported on November 12, 2025 for Q3.
The Actual EPS was $-0.30, which beat the estimate of $-0.36.
The Actual Revenue was $2.2M, which beat the estimate of $2.1M.
Browse earnings estimates, EPS, and revenue on all stocks.